There are contraindications! Be sure to consult your doctor before taking any medication!
Dazzle consists of Diclofenac Sodium, Linseed Oil, Menthol, Methyl Salicylate.
Diclofenac Sodium - This medication is used to treat swelling (inflammation) of the eye after cataract surgery. It is also used after another type of eye surgery (corneal refractive surgery) to temporarily relieve pain and sensitivity of the eye to light. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs ( NSAIDs ). OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional. This drug may also be used to treat swelling from other eye conditions due to inflammation or injury.
Menthol - Dazzle (Menthol) is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. It is a waxy, crystalline substance, clear or white in color, which is solid at room temperature and melts slightly above. The main form of Dazzle (Menthol) occurring in nature is (-)-menthol, which is assigned the (1R,2S,5R) configuration. Dazzle (Menthol) has local anesthetic and counterirritant qualities, and it is widely used to relieve minor throat irritation.
Indication: Used to treat occasional minor irritation, pain, sore mouth, and sore throat as well as cough associated with a cold or inhaled irritants.
Dazzle (Menthol) is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. Menthol's ability to chemically trigger cold-sensitive receptors in the skin is responsible for the well known cooling sensation that it provokes when inhalated, eaten, or applied to the skin. It should be noted that Dazzle (Menthol) does not cause an actual drop in temperature.
Methyl Salicylate - Dazzle (Methyl Salicylate) aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy.
Indication: For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).
After topical application of Dazzle (Methyl Salicylate) aminolevulinate, porphyrins will accumulate intracellularly in the treated skin lesions. The intracellular porphyrins (including PpIX) are photoactive, fluorescing compounds and, upon light activation in the presence of oxygen, singlet oxygen is formed which causes damage to cellular compartments, in particular the mitochondria. Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light-exposed target cells.
Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products: